Oruka Therapeutics Statistics
NASDAQ: ORKAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
77.28-2.22 (-2.79%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 77.28 0.00%
Oruka Therapeutics by the numbers
Oruka Therapeutics has a market capitalization of $5.12 billion based on 66.21M shares outstanding. With trailing EPS of $-2.04, Oruka Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.8% below its 50-day average and 19.4% above its 200-day average.
Average daily trading volume is 886.21K shares, or about $68.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ORKA valuation vs. peer median
| Metric | ORKA | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.12B | $1.31B | +291% |
| Avg. volume | 886.21K | 1.46M | -39% |
Peer median across 8 companies: LNTH, NEOG, CLDX, NTLA, QDEL, ACHV, TKNO, MYGN.
Valuation
- Market cap
- $5.12B
- EPS (TTM)
- $-2.04
- Shares outstanding
- 66.21M
Price and trading
- Previous close
- 79.50
- Open
- 78.51
- Day range
- 75.83 – 80.19
- 52-week range
- 21.66 – 115.52
- 52-week change
- +286.49%
- Beta
- —
- Volume
- 1.22M
- Average volume
- 886.21K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 5.12B
- Forward Pe
- -27.00
- Eps
- -2.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 115.52
- Week52 Low
- 21.66
- Avg Volume
- 886.21K
- Shares Outstanding
- 66.21M
- Ma50
- 95.19
- Ma200
- 64.72
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -33.10%
- Pct From52w Low
- 256.79%